세계의 소양증 치료제 시장 보고서(2024년)

Pruritus Therapeutics Global Market Report 2024

US $ 5,000 ￦ 7,062,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,593,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,125,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

소양증 치료제 시장 규모는 향후 몇 년동안 크게 성장할 것으로 예상됩니다. 2028년까지 5.6%의 연평균 복합 성장률(CAGR)로 149억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 확대는 소양증 병태생리에 대한 광범위한 이해, 제형 및 전달 방법의 발전, 개인 맞춤형 의료에 대한 관심, 피부과학 연구 및 개발의 급증, 인식 및 진단율 증가, 관심 증가와 관련이 있을 수 있습니다. 예측 기간 동안 예상되는 주목할 만한 동향으로는 소양증 특이적 수용체 작용제 및 길항제 개발, 맞춤 치료 접근법에 대한 시장의 집중, 소양증 모니터링 및 관리의 기술 통합, 다학제적 연구를 위한 공동의 노력 등이 있습니다.

소양증 치료제 시장은 피부 질환의 발생률 증가로 인해 성장할 것으로 예상됩니다. 피부 질환에는 좌창, 습진, 피부암, 곰팡이 감염 등 피부, 모발, 손톱, 점막에 영향을 미치는 다양한 질환이 포함됩니다. 소양증 치료는 국소 치료, 피부 연화제, 면역 억제제, 특정 소양증 치료제 등 소양증의 근본적인 원인에 따라 결정되는 경우가 많습니다. 미국 암 협회의 보고서에 따르면 2020년부터 2021년까지 피부암 발병 건수가 5.8% 증가하여 108,480건에 이르렀다고 합니다. 이러한 피부 질환의 급증은 소양증 치료제 시장의 성장 동력이 되고 있습니다.

세계 노인 인구 증가는 안과용 임플란트 시장 확대에 기여할 것으로 예상됩니다. 65세 이상 노인을 포함한 노인들은 노화에 따른 다양한 요인으로 인해 안구건조증에 걸리기 쉽다. 세계보건기구(WHO)에 따르면 전 세계 60세 이상 인구는 2020년 10억 명에서 2022년까지 14억 명에 달할 것으로 예상됩니다. 고령화 사회의 특수한 요구로 인해 소양증 치료제는 소양증 문제를 해결하는 데 중요한 역할을 합니다. 전 세계 노인 인구 증가는 소양증 치료제 시장의 성장을 가속할 것으로 예상됩니다. 특히 프랑스에 본사를 둔 바이오 제약사 입센(Ipsen)은 2023년 11월 메디슨 파마와 협력하여 생후 6개월 이상의 진행성 가족성 간내 담즙 정체(PFIC) 환자를 위한 혁신적인 소양증 치료제 빌베이(Bilbay)를 개발했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

• 세계의 소양증 치료제 시장 성장 촉진요인과 제약 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 소양증 치료제 시장 규모 실적과 성장, 2018-2023년
• 세계의 소양증 치료제 시장 규모와 성장 예측, 2023년-2028년, 2033년

제6장 시장 세분화

• 세계의 소양증 치료제 시장, 제품별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
• 코르티코스테로이드
• 항히스타민제
• 국소 마취제
• 반자극물질
• 면역억제제
• 칼시뉴린 억제제
• 기타 제품
• 세계의 소양증 치료제 시장, 투여 경로별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
• 경구
• 비경구
• 화제
• 세계의 소양증 치료제 시장, 질환 유형별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
• 아토피 피부염
• 알레르기성 접촉 피부염
• 두드러기
• 피부 T세포
• 기타 질환 유형
• 세계의 소양증 치료제 시장, 최종사용자별 세분화, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
• 병원
• 클리닉
• 기타 최종사용자

제7장 지역 및 국가별 분석

• 세계의 소양증 치료제 시장, 지역별, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 소양증 치료제 시장, 국가별, 분석 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 소양증 치료제 시장 경쟁 구도
• 소양증 치료제 시장 기업 개요
  • Pfizer Inc.
  • Johnson &Johnson
  • AbbVie Inc.
  • Sanofi SA
  • Bristol-Myers Squibb Company

제31장 기타 주요 기업 및 혁신 기업

• Abbott Laboratories
• Eli Lilly and Company
• Amgen Inc.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Brunswick Corporation
• Galderma Laboratories LP
• Cipla Limited
• Vifor Pharma Ltd.
• Carl Zeiss Meditec AG
• LEO Pharma AS
• Mirum Pharmaceuticals Inc.
• Cara Therapeutics Inc.
• GlaxoSmithKline Plc

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 가능성 분석

제36장 부록

LSH

영문 목차

영문목차

Pruritus therapeutics pertains to the treatments employed to alleviate an uncomfortable skin sensation prompting a desire to scratch. This approach is commonly applied to alleviate swelling and inflammation in moderate-to-severe inflammatory skin conditions.

The primary product categories of pruritus therapeutics encompass corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids denote synthetic anti-inflammatory medications utilized to address itching and inflammation resulting from pruritus. These medications can be administered through various routes, including oral, parenteral, and topical, aiding in the treatment of diverse disease types such as atopic dermatitis, allergic contact dermatitis, urticaria, cutaneous T-cell, among others. They find application in hospitals, clinics, and other medical settings.

The pruritus therapeutics research market report is one of a series of new reports from The Business Research Company that provides pruritus therapeutics market statistics, including pruritus therapeutics industry global market size, regional shares, competitors with a pruritus therapeutics market share, detailed pruritus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutics industry. This pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutics market size has grown strongly in recent years. It will grow from $11.39 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The increase observed during the historical period can be ascribed to a rise in the incidence of pruritus, a variety of causes and conditions, the growing aging population, and a heightened focus on improving patient quality of life.

The pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The expansion projected for the forecast period can be linked to the broader understanding of pruritus pathophysiology, advancements in drug formulations and delivery methods, a spotlight on personalized medicine, a surge in dermatological research and development, heightened awareness and diagnosis rates, and an increasing interest in botanical and herbal remedies. Noteworthy trends anticipated during the forecast period encompass the development of itch-specific receptor agonists and antagonists, a market emphasis on personalized therapeutic approaches, the integration of technology in itch monitoring and management, and collaborative efforts for cross-disciplinary research.

The pruritus therapeutics market is anticipated to witness growth due to the increasing incidence of dermatological disorders. Dermatological disorders encompass a range of conditions affecting the skin, hair, nails, and mucous membranes, including acne, eczema, skin cancer, and fungal infections. The use of pruritus treatments is often determined by the underlying cause of itching, involving topical treatments, emollients, immunosuppressant medications, and specific itching medications. A report by the American Cancer Society Inc. revealed a 5.8% increase in skin cancer cases from 2020 to 2021, reaching 108,480 cases. This surge in dermatological disorders is a driving force behind the growth of the pruritus therapeutics market.

The global increase in the geriatric population is expected to contribute to the expansion of the ocular implant market. The geriatric population, comprising individuals aged 65 and older, is more susceptible to pruritus due to various factors associated with aging. According to the World Health Organization, the global population of individuals aged 60 and above is projected to reach 1.4 billion by 2022, compared to 1 billion in 2020. The aging population's specific needs make pruritus therapeutics crucial in addressing itching concerns. The rise in the geriatric population worldwide is poised to drive the growth of the pruritus therapeutics market. Notably, Ipsen, a France-based biopharmaceutical company, collaborated with Medison Pharma in November 2023 to develop an innovative pruritus treatment, Bylvay, for patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis (PFIC).

A prominent trend in the pruritus therapeutics market is product innovation, with major companies focusing on developing novel treatments to strengthen their market position. For instance, in August 2021, Fresenius Medical Care AG & Co., a Germany-based provider for people with kidney illnesses, launched KORSUVA (difelikefalin) for reducing pruritus related to chronic kidney dysfunction in adults undergoing hemodialysis. This therapeutic injectable drug, approved by the FDA, is a first-in-class kappa opioid receptor (KOR) targeting the outer neurological system. Product innovation remains a key strategy for companies aiming to enhance the safety and effectiveness of pruritus treatments.

Leading companies in the pruritus therapeutics market are concentrating on the development of oral solutions for managing cholestatic pruritus in patients with Alagille syndrome (ALGS) aged one year and older. An oral solution for cholestatic pruritus is a liquid medication designed to alleviate itching associated with liver conditions. In September 2021, Mirum Pharmaceuticals, Inc., a US-based biotechnology company, received FDA approval for LIVMARLI (maralixibat) oral solution to manage cholestatic pruritus in individuals aged one year and older with ALGS. The company's Mirum Access Plus (MAP) program provides access to LIVMARLI, offering support services, insurance coverage, and financial assistance through dedicated coordinators.

In March 2023, Ipsen, the France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based clinical-stage biopharmaceutical company. This strategic acquisition aims to expand Ipsen's portfolio by incorporating promising medicines for pediatric and adult uncommon cholestatic liver disorders. Albireo Pharma, Inc., specializes in oral drugs, including the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC). The acquisition enriches Ipsen's capabilities with unique pipeline potential and scientific and commercial expertise.

Major companies operating in the pruritus therapeutics market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Eli Lilly and Company, Amgen Inc. , Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Brunswick Corporation, Galderma Laboratories LP, Cipla Limited, Vifor Pharma Ltd., Carl Zeiss Meditec AG, LEO Pharma AS, Mirum Pharmaceuticals Inc., Cara Therapeutics Inc., GlaxoSmithKline PLC, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

North America was the largest region in the pruritus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutics market consists of revenues earned by entities by providing topical therapy, phototherapy, and systemic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The pruritus therapeutics market also include sales of hydroxyzine, benadryl, banophen, diphedryl, and allermax. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pruritus Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressants; Calcineurin Inhibitors; Other Products
• 2) By Route of Administration: Oral; Parenteral; Topical
• 3) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
• 4) By End-User: Hospitals; Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pruritus Therapeutics Market Characteristics

3. Pruritus Therapeutics Market Trends And Strategies

4. Pruritus Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pruritus Therapeutics Market Size and Growth

• 5.1. Global Pruritus Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pruritus Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pruritus Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pruritus Therapeutics Market Segmentation

• 6.1. Global Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Other Products
• 6.2. Global Pruritus Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Topical
• 6.3. Global Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Cutaneous T-Cell
• Other Disease Types
• 6.4. Global Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End Users

7. Pruritus Therapeutics Market Regional And Country Analysis

• 7.1. Global Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pruritus Therapeutics Market

• 8.1. Asia-Pacific Pruritus Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pruritus Therapeutics Market

• 9.1. China Pruritus Therapeutics Market Overview
• 9.2. China Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pruritus Therapeutics Market

• 10.1. India Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pruritus Therapeutics Market

• 11.1. Japan Pruritus Therapeutics Market Overview
• 11.2. Japan Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pruritus Therapeutics Market

• 12.1. Australia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pruritus Therapeutics Market

• 13.1. Indonesia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pruritus Therapeutics Market

• 14.1. South Korea Pruritus Therapeutics Market Overview
• 14.2. South Korea Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pruritus Therapeutics Market

• 15.1. Western Europe Pruritus Therapeutics Market Overview
• 15.2. Western Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pruritus Therapeutics Market

• 16.1. UK Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pruritus Therapeutics Market

• 17.1. Germany Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pruritus Therapeutics Market

• 18.1. France Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pruritus Therapeutics Market

• 19.1. Italy Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pruritus Therapeutics Market

• 20.1. Spain Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pruritus Therapeutics Market

• 21.1. Eastern Europe Pruritus Therapeutics Market Overview
• 21.2. Eastern Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pruritus Therapeutics Market

• 22.1. Russia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pruritus Therapeutics Market

• 23.1. North America Pruritus Therapeutics Market Overview
• 23.2. North America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pruritus Therapeutics Market

• 24.1. USA Pruritus Therapeutics Market Overview
• 24.2. USA Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pruritus Therapeutics Market

• 25.1. Canada Pruritus Therapeutics Market Overview
• 25.2. Canada Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pruritus Therapeutics Market

• 26.1. South America Pruritus Therapeutics Market Overview
• 26.2. South America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pruritus Therapeutics Market

• 27.1. Brazil Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pruritus Therapeutics Market

• 28.1. Middle East Pruritus Therapeutics Market Overview
• 28.2. Middle East Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pruritus Therapeutics Market

• 29.1. Africa Pruritus Therapeutics Market Overview
• 29.2. Africa Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pruritus Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Pruritus Therapeutics Market Competitive Landscape
• 30.2. Pruritus Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol-Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pruritus Therapeutics Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc.
• 31.4. Regeneron Pharmaceuticals Inc.
• 31.5. Astellas Pharma Inc.
• 31.6. Bausch Health Companies Inc.
• 31.7. Brunswick Corporation
• 31.8. Galderma Laboratories LP
• 31.9. Cipla Limited
• 31.10. Vifor Pharma Ltd.
• 31.11. Carl Zeiss Meditec AG
• 31.12. LEO Pharma AS
• 31.13. Mirum Pharmaceuticals Inc.
• 31.14. Cara Therapeutics Inc.
• 31.15. GlaxoSmithKline Plc

32. Global Pruritus Therapeutics Market Competitive Benchmarking

33. Global Pruritus Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pruritus Therapeutics Market

35. Pruritus Therapeutics Market Future Outlook and Potential Analysis

• 35.1 Pruritus Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pruritus Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pruritus Therapeutics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료